The immunization of people against the coronavirus using homegrown COVIRAN BAREKAT vaccine is underway across the country for the age group above 68 years.
On June 14, COVIRAN BAREKAT received the license for public use. Results of the second human trial phase showed that the vaccine creates immunity by 93.5 percent, he noted.
Eleven countries from Asia and South America, and a European country have asked for importing the vaccine.
Related posts:
Internal documents show Big Oil PR messages still ‘mislead’ public on climate
Stop Using The Word ‘Goy’: You’re Empowering White Supremacists
Statement of Non-Compliance with Mandatory Vaccination in Canadian Universities
The Papal Public Relations Operation Behind Christopher Columbus’ Discovery Of The New World
Petition to ban China flag in public in Taiwan reached signature threshold and must receive governme...
Clintons, Clooney, Oprah Among Public Figures Celebrating Marion Wiesel’s 90th Birthday